Genedrive (GDR) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 Mar 2019 07:00 AM
RNS
Half-year Report
16 Jan 2019 01:21 PM
RNS
Holding(s) in Company
15 Jan 2019 07:00 AM
RNS
Trading update
31 Dec 2018 11:30 AM
RNS
Result of AGM
12 Dec 2018 07:49 AM
RNS
Holding(s) in Company
11 Dec 2018 07:15 AM
EQS
genedrive plc (GDR): Accelerating into fiscal 2...
10 Dec 2018 04:44 PM
RNS
Holding(s) in Company
10 Dec 2018 03:40 PM
RNS
Holding(s) in Company
10 Dec 2018 11:04 AM
RNS
Holding(s) in Company
07 Dec 2018 03:07 PM
RNS
2018 Annual Report and AGM Notice
07 Dec 2018 02:59 PM
RNS
Result of GM
29 Nov 2018 07:00 AM
RNS
AbbVie to use HCV assay in study
19 Nov 2018 03:27 PM
RNS
Posting of Shareholder Circular
16 Nov 2018 01:42 PM
RNS
Result of Equity Placing
16 Nov 2018 07:00 AM
RNS
Unaudited Preliminary Results
16 Nov 2018 07:00 AM
RNS
Proposed Placing and Broker Option
10 Sep 2018 01:46 PM
RNS
Director/PDMR Shareholding
24 Aug 2018 07:00 AM
RNS
Notice of GM
22 Aug 2018 07:00 AM
RNS
Board Appointment
08 Aug 2018 07:00 AM
RNS
genedrive partners with FIND to evaluate HCV test
19 Jul 2018 07:00 AM
RNS
Director/PDMR Shareholding
13 Jul 2018 07:00 AM
RNS
Trading Update
29 Jun 2018 09:36 AM
RNS
Total Voting Rights
27 Jun 2018 07:15 AM
EQS
genedrive plc (GDR): Preventing hearing loss in...
20 Jun 2018 07:00 AM
RNS
Grant for NHS point-of-care test
19 Jun 2018 11:18 AM
RNS
Additional Listing of Shares
11 Jun 2018 09:25 AM
RNS
Completion of Disposal
04 Jun 2018 04:47 PM
RNS
Result of General Meeting
17 May 2018 02:32 PM
RNS
Circular re Proposed Disposal
14 May 2018 05:39 PM
RNS
Proposed disposal for up to £1.9 million in cash
10 May 2018 11:39 AM
RNS
Holding(s) in Company
18 Apr 2018 07:00 AM
RNS
genedrive plc to Present at the UK Investor Show
12 Apr 2018 09:51 AM
EQS
Hardman & Co Research: genedrive plc (GDR):...
10 Apr 2018 07:00 AM
RNS
Publication of Genedrive Performance Data in Gut
09 Apr 2018 09:06 AM
RNS
Directorate Change
04 Apr 2018 08:48 AM
RNS
Director/PDMR Shareholding
03 Apr 2018 07:00 AM
RNS
Genedrive® Hepatitis C test in Asia Pacific
27 Mar 2018 07:00 AM
RNS
genedrive signs distribution agreement for India
20 Mar 2018 03:40 PM
RNS
Holding(s) in Company
20 Mar 2018 07:00 AM
RNS
Interim Results
13 Mar 2018 07:00 AM
RNS
Commercial sales of Genedrive® HCV ID Kit begin
27 Feb 2018 07:00 AM
RNS
genedrive Receives Funding for TB Test Development
14 Feb 2018 07:00 AM
RNS
Notice of Results
18 Jan 2018 11:59 AM
RNS
Hardman Res: Hep-C point-of-care test launched
17 Jan 2018 02:01 PM
RNS
Holding(s) in Company
17 Jan 2018 07:00 AM
RNS
Trading update
16 Jan 2018 07:00 AM
RNS
First Successful Field Evaluation of HCV Assay
13 Dec 2017 07:15 AM
RNS
Hardman Research: Remodelled for growth
07 Dec 2017 04:28 PM
RNS
Director/PDMR Shareholding
29 Nov 2017 02:19 PM
RNS
Result of AGM

Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests. 

 Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss

Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.

GDR share price launched at 129p in 2007. 

UK 100

Latest directors dealings